Neurological and Cognitive Neurorehabilitation in a Parkinson's rehabilitation unit in GermanyName : Dr. Mauricio Parra
Affliation : Psychology
University : Friedrich Schiller University Jena
Country : Germany
Parkinson's disease is the second commonest neurodegenerative disorder in Germany after Alzheimer disease, resulting in both motor and non-motor symptoms with cognitive impairments that significantly reduce ADL's abilities and quality of life. In our Parkinson's rehabilitation unit treatment consists of both pharmaceutical and non-pharmaceutical treatment approaches.
The primary scope in our rehabilitation of Parkinson-related motor symptoms is the pharmacological treatment in terms of evidence-based pharmaceutical medicine in order to improve motor deficits that allow a better motor and mobility independence of Parkinson's patients. The second scope of our neurorehabilitation unit is an important non-pharmaceutical treatment approach conducted by different therapeutically groups (physiotherapy, occupational therapy, language therapy, and neuropsychology), and a prime component of this is formed by the training of Behavioural adaptations that can assist patients to cope better with their motor and non-motor symptoms. This interdisciplinary therapy is supervised by the neurological physician for evaluation, treatment progress and therapy adjustments. Optimal delivery of neurorehabilitation requires personalized approach in order to increase rehabilitative motivation. In this literature review we will discuss with a case of our section the possibilities of both pharmaceutical and non-pharmaceutical treatment approaches in the field of neurorehabilitation for Parkinson's disease. Specifically, we will focus on actual and relatively new rehabilitation developments that are possible in the clinical practice in hospital-setting of basically 2-3 weeks neurology-based rehabilitation treatment with follow-up. Evidence in these new field is growing, based on good clinical trials.